Singular Genomics Systems Stock Price Prediction
| OMIC Stock | USD 21.37 0.05 0.23% |
Oversold Vs Overbought
75
Oversold | Overbought |
EPS Estimate Next Quarter (8.01) | EPS Estimate Current Year (34.45) | EPS Estimate Next Year (31.28) | Wall Street Target Price 12.45 | EPS Estimate Current Quarter (8.05) |
Using Singular Genomics hype-based prediction, you can estimate the value of Singular Genomics Systems from the perspective of Singular Genomics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Singular Genomics to buy its stock at a price that has no basis in reality. In that case, they are not buying Singular because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Singular Genomics after-hype prediction price | USD 19.48 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Singular |
Singular Genomics After-Hype Price Prediction Density Analysis
As far as predicting the price of Singular Genomics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Singular Genomics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Singular Genomics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Singular Genomics Estimiated After-Hype Price Volatility
In the context of predicting Singular Genomics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Singular Genomics' historical news coverage. Singular Genomics' after-hype downside and upside margins for the prediction period are 1.73 and 37.23, respectively. We have considered Singular Genomics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Singular Genomics is very risky at this time. Analysis and calculation of next after-hype price of Singular Genomics Systems is based on 3 months time horizon.
Singular Genomics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Singular Genomics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Singular Genomics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Singular Genomics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.86 | 17.75 | 1.89 | 0.20 | 8 Events / Month | 3 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
21.37 | 19.48 | 8.84 |
|
Singular Genomics Hype Timeline
Singular Genomics Systems is now traded for 21.37. The entity has historical hype elasticity of -1.89, and average elasticity to hype of competition of -0.2. Singular is forecasted to decline in value after the next headline, with the price expected to drop to 19.48. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -8.84%, whereas the daily expected return is now at 2.86%. The volatility of related hype on Singular Genomics is about 24767.44%, with the expected price after the next announcement by competition of 21.17. About 14.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.44. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Singular Genomics Systems recorded a loss per share of 34.68. The entity had not issued any dividends in recent years. The firm had 1:30 split on the 26th of June 2024. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Singular Genomics Basic Forecasting Models to cross-verify your projections.Singular Genomics Related Hype Analysis
Having access to credible news sources related to Singular Genomics' direct competition is more important than ever and may enhance your ability to predict Singular Genomics' future price movements. Getting to know how Singular Genomics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Singular Genomics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BEAT | Heartbeam | (0.27) | 8 per month | 3.42 | 0.06 | 10.30 | (6.23) | 22.69 | |
| EUDA | EUDA Health Holdings | 0.07 | 1 per month | 6.79 | (0.0009) | 9.70 | (10.50) | 26.33 | |
| NUTX | Nutex Health | (0.42) | 9 per month | 5.37 | 0.11 | 11.28 | (9.19) | 47.75 | |
| HCTI | Healthcare Triangle | 0.04 | 4 per month | 8.74 | 0.09 | 10.34 | (18.35) | 131.09 | |
| MGRX | Mangoceuticals, Common Stock | 0.16 | 7 per month | 0.00 | (0.10) | 7.29 | (10.11) | 37.65 | |
| ACON | Aclarion | (0.01) | 7 per month | 0.00 | (0.06) | 11.11 | (10.00) | 35.83 |
Singular Genomics Additional Predictive Modules
Most predictive techniques to examine Singular price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Singular using various technical indicators. When you analyze Singular charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Singular Genomics Predictive Indicators
The successful prediction of Singular Genomics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Singular Genomics Systems, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Singular Genomics based on analysis of Singular Genomics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Singular Genomics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Singular Genomics's related companies. | 2023 | 2024 (projected) | Graham Number | 254.68 | 164.94 | Receivables Turnover | 1.84 | 1.93 |
Story Coverage note for Singular Genomics
The number of cover stories for Singular Genomics depends on current market conditions and Singular Genomics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Singular Genomics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Singular Genomics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Singular Genomics Short Properties
Singular Genomics' future price predictability will typically decrease when Singular Genomics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Singular Genomics Systems often depends not only on the future outlook of the potential Singular Genomics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Singular Genomics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.4 M | |
| Cash And Short Term Investments | 173.9 M |
Complementary Tools for Singular Stock analysis
When running Singular Genomics' price analysis, check to measure Singular Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Singular Genomics is operating at the current time. Most of Singular Genomics' value examination focuses on studying past and present price action to predict the probability of Singular Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Singular Genomics' price. Additionally, you may evaluate how the addition of Singular Genomics to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |